Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
AstraZeneca
Origin Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
UMC Utrecht
BeOne Medicines
Memorial Sloan Kettering Cancer Center
ViroMissile, Inc.
Arcus Biosciences, Inc.
AstraZeneca
AstraZeneca
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Clasp Therapeutics, Inc.
Eli Lilly and Company
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
Eli Lilly and Company
Boehringer Ingelheim
Adela, Inc
IDEAYA Biosciences
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin
Elephas
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals
Elephas
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Pfizer
University Health Network, Toronto
NeoTX Therapeutics Ltd.
BicycleTx Limited
IDEAYA Biosciences
National Institutes of Health Clinical Center (CC)
Rondo Therapeutics
Actym Therapeutics, Inc.
University of Arizona
Memorial Sloan Kettering Cancer Center